Discoveries and Developments of CXCR4-targeted HIV-1 Entry Inhibitors

Overview

Journal Exp Biol Med (Maywood)

Specialty Biology

Date 2020 Feb 6

PMID 32019336

Citations 9

Authors

Chaozai Zhang

Ruohan Zhu

Qizhi Cao

Xiaohong Yang

Ziwei Huang

Jing An

Affiliations

Soon will be listed here.

Citing Articles

Viral Factors in Modulation of Host Immune Response: A Route to Novel Antiviral Agents and New Therapeutic Approaches.

Tarasova O, Petrou A, Ivanov S, Geronikaki A, Poroikov V Int J Mol Sci. 2024; 25(17).

PMID: 39273355 PMC: 11395507. DOI: 10.3390/ijms25179408.

In Vitro Anti-HIV-1 Activity of Fucoidans from Brown Algae.

Nosik M, Krylova N, Usoltseva R, Surits V, Kireev D, Shchelkanov M Mar Drugs. 2024; 22(8).

PMID: 39195471 PMC: 11355542. DOI: 10.3390/md22080355.

C-X-C motif chemokine ligand 12-C-X-C chemokine receptor type 4 signaling axis in cancer and the development of chemotherapeutic molecules.

Yen J, Chang C, Hsu H, Yang C, Mani H, Liou J Tzu Chi Med J. 2024; 36(3):231-239.

PMID: 38993827 PMC: 11236080. DOI: 10.4103/tcmj.tcmj_52_24.

Current drugs for HIV-1: from challenges to potential in HIV/AIDS.

Peng Y, Zong Y, Wang D, Chen J, Chen Z, Peng F Front Pharmacol. 2023; 14:1294966.

PMID: 37954841 PMC: 10637376. DOI: 10.3389/fphar.2023.1294966.

Elucidating the Gene Signatures and Immune Cell Types in HIV-Infected Immunological Non-Responders by Bioinformatics Analyses.

Xiao Q, Han J, Yu F, Yan L, Li Q, Lao X Int J Gen Med. 2022; 15:8491-8507.

PMID: 36514742 PMC: 9741855. DOI: 10.2147/IJGM.S390642.

References

Cox B, Prosser A, Sun Y, Li Z, Lee S, Huang M . Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase. ACS Med Chem Lett. 2015; 6(7):753-7. PMC: 4499816. DOI: 10.1021/acsmedchemlett.5b00036. View

Tamamura H, Hiramatsu K, Ueda S, Wang Z, Kusano S, Terakubo S . Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131. J Med Chem. 2005; 48(2):380-91. DOI: 10.1021/jm049429h. View

Wu L, Gerard N, Wyatt R, Choe H, Parolin C, Ruffing N . CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 1996; 384(6605):179-83. DOI: 10.1038/384179a0. View

Zhang C, Huang L, Zhu R, Meng Q, Zhu S, Xu Y . High affinity CXCR4 inhibitors generated by linking low affinity peptides. Eur J Med Chem. 2019; 172:174-185. PMC: 6677133. DOI: 10.1016/j.ejmech.2019.03.056. View

BERGER E, Doms R, Fenyo E, Korber B, Littman D, Moore J . A new classification for HIV-1. Nature. 1998; 391(6664):240. DOI: 10.1038/34571. View

Wu C, Wang C, Chang C, Cheng Y, Song J, Jan J . Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors. J Med Chem. 2015; 58(3):1452-65. PMC: 4823997. DOI: 10.1021/jm501772w. View

Mamede J, Cianci G, Anderson M, Hope T . Early cytoplasmic uncoating is associated with infectivity of HIV-1. Proc Natl Acad Sci U S A. 2017; 114(34):E7169-E7178. PMC: 5576815. DOI: 10.1073/pnas.1706245114. View

Huang M, Giesler K, Katzman B, Prosser A, Truax V, Liotta D . Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells. Oncotarget. 2018; 9(24):16996-17013. PMC: 5908301. DOI: 10.18632/oncotarget.24580. View

Zhao H, Prosser A, Liotta D, Wilson L . Discovery of novel N-aryl piperazine CXCR4 antagonists. Bioorg Med Chem Lett. 2015; 25(21):4950-4955. PMC: 5776727. DOI: 10.1016/j.bmcl.2015.04.036. View

10.

Choi W, Duggineni S, Xu Y, Huang Z, An J . Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4). J Med Chem. 2011; 55(3):977-94. PMC: 3476736. DOI: 10.1021/jm200568c. View

11.

Xu Y, Duggineni S, Espitia S, Richman D, An J, Huang Z . A synthetic bivalent ligand of CXCR4 inhibits HIV infection. Biochem Biophys Res Commun. 2013; 435(4):646-50. PMC: 3752463. DOI: 10.1016/j.bbrc.2013.05.038. View

12.

Qin L, Kufareva I, Holden L, Wang C, Zheng Y, Zhao C . Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine. Science. 2015; 347(6226):1117-22. PMC: 4362693. DOI: 10.1126/science.1261064. View

13.

Kumar S, Choi W, Dong C, Madani N, Tian S, Liu D . SMM-chemokines: a class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and leads for therapeutic development. Chem Biol. 2006; 13(1):69-79. DOI: 10.1016/j.chembiol.2005.10.012. View

14.

Murakami T, Niwa M, Tokunaga F, Miyata T, Iwanaga S . Direct virus inactivation of tachyplesin I and its isopeptides from horseshoe crab hemocytes. Chemotherapy. 1991; 37(5):327-34. DOI: 10.1159/000238875. View

15.

Pennings P . HIV Drug Resistance: Problems and Perspectives. Infect Dis Rep. 2014; 5(Suppl 1):e5. PMC: 3892620. DOI: 10.4081/idr.2013.s1.e5. View

16.

Alkhatib G, Combadiere C, Broder C, Feng Y, Kennedy P, Murphy P . CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996; 272(5270):1955-8. DOI: 10.1126/science.272.5270.1955. View

17.

Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y . A CCR5 memory subset within HIV-1-infected primary resting CD4 T cells is permissive for replication-competent, latently infected viruses in vitro. BMC Res Notes. 2019; 12(1):242. PMC: 6489248. DOI: 10.1186/s13104-019-4281-5. View

18.

Tan S, Yang B, Liu J, Xun T, Liu Y, Zhou X . Penicillixanthone A, a marine-derived dual-coreceptor antagonist as anti-HIV-1 agent. Nat Prod Res. 2017; 33(10):1467-1471. DOI: 10.1080/14786419.2017.1416376. View

19.

Murakami T, Kumakura S, Yamazaki T, Tanaka R, Hamatake M, Okuma K . The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100. Antimicrob Agents Chemother. 2009; 53(7):2940-8. PMC: 2704660. DOI: 10.1128/AAC.01727-08. View

20.

Verrier F, Borman A, Brand D, Girard M . Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage. AIDS Res Hum Retroviruses. 1999; 15(8):731-43. DOI: 10.1089/088922299310827. View